Identification of human preformed antibody targets in GTKO pigs

Xenotransplantation

Volumn 19, Issue 2, 2012, Pages 92-101

  Burlak, Christopher ^a   Wang, Zheng Yu ^a   Chihara, Ray K ^a   Lutz, Andrew J ^a   Wang, Yueren ^a   Estrada, Jose L ^a   Tector, A Joseph ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

galactosyltransferase knockout pigs; Xenoantigens; Xenograft rejection; Xenotransplantation

Indexed keywords

ALPHA ENOLASE; DRUG; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UVOMORULIN;

ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; GRAFT REJECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; KNOCKOUT GENE; LIVER CELL; LIVER GRAFT; LIVER SINUSOID; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, HETEROPHILE; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, HETEROPHILE; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIAL CELLS; GALACTOSYLTRANSFERASES; GENE KNOCKOUT TECHNIQUES; GRAFT REJECTION; HEPATOCYTES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUS SCROFA; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES;

EID: 84859854200     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2012.00695.x     Document Type: Article

References (30)

1. LIN SS, KOOYMAN DL, DANIELS LJ et al. The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transpl Immunol 1997; 5: 212-218.
2. COZZI E, WHITE DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964-966.
3. LAI L, KOLBER-SIMONDS D, PARK KW et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089-1092.
4. EKSER B, RIGOTTI P, GRIDELLI B, COOPER DK. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol 2009; 21: 87-92.
5. BYRNE GW, SCHIRMER JM, FASS DN et al. Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant 2005; 5: 1011-1020.
6. COZZI E, SEVERO M, BOSIO E, BESENZON F, ANCONA E. Antibody mediated rejection in pig-to-nonhuman primate xenotransplantation models. Curr Drug Targets Cardiovasc Haematol Disord 2005; 5: 233-253.
7. BURLAK C, PARIS LL, CHIHARA RK et al. The fate of human platelets perfused through the pig liver: implications for xenotransplantation. Xenotransplantation 2010; 17: 350-361.
8. ESTRADA J, SOMMER J, COLLINS B et al. Swine generated by somatic cell nuclear transfer have increased incidence of intrauterine growth restriction (IUGR). Cloning Stem Cells 2007; 9: 229-236.
9. WAGHMARE S, ESTRADA J, REYES L et al. Gene Targeting and Cloning in Pigs Using Fetal Liver Derived Cells. J Surg Res 2011; 171: e223-e229.
10. PARIS LL, CHIHARA RK, REYES LM et al. ASGR1 expressed by porcine enriched liver sinusoidal endothelial cells mediates human platelet phagocytosis in vitro. Xenotransplantation 2011; 18: 245-251.
11. SHAO C, DENG L, HENEGARIU O et al. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice. Proc Natl Acad Sci USA 1999; 96: 9230-9235.
12. CHEN G, QIAN H, STARZL T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 1295-1298.
13. THIBAUDEAU K, BORCHE L, SOULILLOU JP, BLANCHARD D. Characterization of porcine platelet glycoproteins recognized by human natural "anti-gal" antibodies. Blood 1996; 87: 4636-4642.
14. YEH P, EZZELARAB M, BOVIN N et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010; 17: 197-206.
15. ZHU A, HURST R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002; 9: 376-381.
16. KIERNAN K, HARNDEN I, GUNTHART M, GREGORY C, MEISNER J, KEARNS-JONKER M. The anti-non-gal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors. Am J Transplant 2008; 8: 1829-1839.
17. SAETHRE M, BAUMANN BC, FUNG M, SEEBACH JD, MOLLNES TE. Characterization of natural human antinon- gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Transplantation 2007; 84: 244-250.
18. GALILI U, ANARAKI F, THALL A, HILL-BLACK C, RADIC M. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993; 82: 2485-2493.
19. GALILI U, MACHER BA, BUEHLER J, SHOHET SB. Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1-3)-linked galactose residues. J Exp Med 1985; 162: 573-582.
20. MCMORROW IM, COMRACK CA, SACHS DH, DERSIMONIAN H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. Transplantation 1997; 64: 501-510.
21. BYRNE GW, STALBOERGER PG, DAVILA E et al. Proteomic identification of non-Gal antibody targets after pig-toprimate cardiac xenotransplantation. Xenotransplantation 2008; 15: 268-276.
22. PLATT JL, HOLZKNECHT ZE. Porcine platelet antigens recognized by human xenoreactive natural antibodies. Transplantation 1994; 57: 327-335.
23. TERRIER B, DEGAND N, GUILPAIN P, SERVETTAZ A, GUILLEVIN L, MOUTHON L. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev 2007; 6: 176-182.
24. FONTAN PA, PANCHOLI V, NOCIARI MM, FISCHETTI VA. Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae. J Infect Dis 2000; 182: 1712-1721.
25. SUNDSTROM P, ALIAGA GR. Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme. J Bacteriol 1992; 174: 6789-6799.
26. FOROOGHIAN F, CHEUNG RK, SMITH WC, O'CONNOR P, DOSCH HM. Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. J Clin Immunol 2007; 27: 388-396.
27. CAPELLO M, FERRI-BORGOGNO S, CAPPELLO P, NOVELLI F. alpha-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J 2011; 278: 1064-1074.
28. TOMAINO B, CAPPELLO P, CAPELLO M et al. Circulating autoantibodies to phosphorylated alpha-enolase are a hallmark of pancreatic cancer. J Proteome Res 2011; 10: 105-112.
29. VERMEULEN N, VERMEIRE S, ARIJS I et al. Seroreactivity against glycolytic enzymes in inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 557-564.
30. PARK JY, PARK MR, KWON DN et al. Alpha 1,3-galactosyltransferase deficiency in pigs increases sialyltransferase activities that potentially raise non-gal xenoantigenicity. J Biomed Biotechnol 2011; 2011: 560850.